Blood pressure in heart failure management and prevention

被引:20
作者
Maeda, Daichi [1 ]
Dotare, Taishi [1 ]
Matsue, Yuya [1 ]
Teramoto, Kanako [2 ,3 ]
Sunayama, Tsutomu [1 ]
Tromp, Jasper [4 ,5 ,6 ,7 ]
Minamino, Tohru [1 ,8 ]
机构
[1] Juntendo Univ, Grad Sch Med, Dept Cardiovasc Biol & Med, Tokyo, Japan
[2] Natl Heart Ctr, Singapore, Singapore
[3] Natl Cerebral & Cardiovasc Ctr, Dept Biostat, Osaka, Japan
[4] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore
[5] Natl Univ Hlth Syst, Singapore, Singapore
[6] Duke Natl Univ Singapore, Singapore, Singapore
[7] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands
[8] Japan Agcy Med Res & Dev, Japan Agcy Med Res & Dev Core Res Evolutionary Med, Tokyo, Japan
基金
日本学术振兴会;
关键词
Blood pressure; DASH diet; Heart failure; Hypertension; Pharmacotherapy; PRESERVED EJECTION FRACTION; LEFT-VENTRICULAR HYPERTROPHY; LIPID-LOWERING TREATMENT; CONVERTING-ENZYME-INHIBITOR; ASSOCIATION TASK-FORCE; CARDIOVASCULAR-DISEASE; HYPERTENSIVE PATIENTS; WEIGHT-LOSS; ANTIHYPERTENSIVE TREATMENT; AMERICAN-COLLEGE;
D O I
10.1038/s41440-022-01158-x
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Hypertension is a leading cause of heart failure and other cardiovascular diseases. Its role in the pathogenesis of heart failure with reduced ejection fraction (HFrEF) differs from that in heart failure with preserved ejection fraction (HFpEF). Moreover, rigorous blood pressure control may reduce the incidence of heart failure. However, once heart failure develops, prognosis is affected by blood pressure, which may differ between patients with and without heart failure. Therefore, the association between guideline-directed medical therapy (GDMT) for heart failure and its uptitration must be considered for blood pressure management and should not be overlooked. Heart failure medications affect the blood pressure and efficacy per baseline blood pressure value. This review discusses the potential mechanisms by which hypertension leads to HFrEF or HFpEF, the impact of hypertension on incident heart failure, and the recommended approaches for blood pressure management in patients with heart failure.
引用
收藏
页码:817 / 833
页数:17
相关论文
共 138 条
[1]   History of cardiovascular epidemiology in Japan [J].
Adachi, Hisashi ;
Fukumoto, Yoshihiro .
JOURNAL OF CARDIOLOGY, 2023, 81 (02) :196-201
[2]   Effect of Baseline and Changes in Systolic Blood Pressure Over Time on the Effectiveness of Valsartan in the Valsartan Heart Failure Trial [J].
Anand, Inder S. ;
Rector, Thomas S. ;
Kuskowski, Michael ;
Thomas, Sabu ;
Holwerda, N. J. ;
Cohn, Jay N. .
CIRCULATION-HEART FAILURE, 2008, 1 (01) :34-42
[3]  
[Anonymous], 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI [10.1001/jama, 10.1001/jama.288.23.2981, DOI 10.1001/JAMA.288.23.2981]
[4]   A clinical trial of the effects of dietary patterns on blood pressure [J].
Appel, LJ ;
Moore, TJ ;
Obarzanek, E ;
Vollmer, WM ;
Svetkey, LP ;
Sacks, FM ;
Bray, GA ;
Vogt, TM ;
Cutler, JA ;
Windhauser, MM ;
Lin, PH ;
Karanja, N .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (16) :1117-1124
[5]   Effects of Prehypertension and Hypertension Subtype on Cardiovascular Disease in the Asia-Pacific Region [J].
Arima, Hisatomi ;
Murakami, Yoshitaka ;
Lam, Tai Hing ;
Kim, Hyeon Chang ;
Ueshima, Hirotsugu ;
Woo, Jean ;
Suh, Il ;
Fang, Xianghua ;
Woodward, Mark .
HYPERTENSION, 2012, 59 (06) :1118-U96
[6]   Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction [J].
Arundel, Cherinne ;
Lam, Phillip H. ;
Gill, Gauravpal S. ;
Patel, Samir ;
Panjrath, Gurusher ;
Faselis, Charles ;
White, Michel ;
Morgan, Charity J. ;
Allman, Richard M. ;
Aronow, Wilbert S. ;
Singh, Steven N. ;
Fonarow, Gregg C. ;
Ahmed, Ali .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (24) :3054-3063
[7]   Beta-blockers for primary prevention of heart failure in patients with hypertension - Insights from a meta-analysis [J].
Bangalore, Sripal ;
Wild, David ;
Parkar, Sanobar ;
Kukin, Marrick ;
Messerli, Franz H. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (13) :1062-1072
[8]   Treatment of hypertension in patients 80 years of age or older [J].
Beckett, Nigel S. ;
Peters, Ruth ;
Fletcher, Astrid E. ;
Staessen, Jan A. ;
Liu, Lisheng ;
Dumitrascu, Dan ;
Stoyanovsky, Vassil ;
Antikainen, Riitta L. ;
Nikitin, Yuri ;
Anderson, Craig ;
Belhani, Alli ;
Forette, Francoise ;
Rajkumar, Chakravarthi ;
Thijs, Lutgarde ;
Banya, Winston ;
Bulpitt, Christopher J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (18) :1887-1898
[9]   Empagliflozin Improves Cardiovascular and Renal Outcomes in Heart Failure Irrespective of Systolic Blood Pressure [J].
Boehm, Michael ;
Anker, Stefan D. ;
Butler, Javed ;
Filippatos, Gerasimos ;
Ferreira, Joao Pedro ;
Pocock, Stuart J. ;
Mahfoud, Felix ;
Brueckmann, Martina ;
Jamal, Waheed ;
Ofstad, Anne Pernille ;
Schueler, Elke ;
Ponikowski, Piotr ;
Wanner, Christoph ;
Zannad, Faiez ;
Packer, Milton .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 78 (13) :1337-1348
[10]   Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HF [J].
Bohm, Michael ;
Young, Robin ;
Jhund, Pardeep S. ;
Solomon, Scott D. ;
Gong, Jianjian ;
Lefkowitz, Martin P. ;
Rizkala, Adel R. ;
Rouleau, Jean L. ;
Shi, VictorC. ;
Swedberg, Karl ;
Zile, Michael R. ;
Packer, Milton ;
McMurray, John J. V. .
EUROPEAN HEART JOURNAL, 2017, 38 (15) :1132-1143